Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai GoBroad Cancer Hospital is a research-oriented medical institution located in the Shanghai International Medical Zone, specializing in oncology and hematology. As a flagship facility of the GoBroad Healthcare Group, the hospital integrates high-end clinical care with robust clinical research capabilities, particularly focusing on early-stage clinical trials for innovative cancer therapies. The hospital is renowned for its expertise in hematopoietic stem cell transplantation and cellular immunotherapies, such as CAR-T cell therapy. It serves as a critical hub for domestic and international biopharmaceutical companies to conduct Phase I through Phase III clinical trials, bridging the gap between laboratory research and clinical application. The facility features a dedicated Phase I clinical trial center and advanced diagnostic laboratories to support precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai GoBroad Cancer Hospital.